Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

• Main Authors: Nazila FATHI MAROUFI (Author), Amir GHORBANIHAGHJO (Author), Manizheh SAYYAH MELLI (Author), Maryam VAEZI (Author), Zohreh HEKMATI AZAR MEHRABANI (Author), Maryam BANNAZADEH AMIRKHIZ (Author), Nadereh RASHTCHIZADEH (Author)
• Format: Book
• Published: Tehran University of Medical Sciences, 2017-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...